Baseimmune is a series a startup based in United Kingdom. 2 investors tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Baseimmune is a pre-clinical stage biotechnology company building a technology platform to design broadly protective vaccines and immunotherapies against highly mutating pathogens, such as influenza and coronavirus.
Stage
series-a
Investors
2
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky